Done, Reygn (2025). Understanding the regulators of adaptive tolerance in chronically stimulated CD4+ T-cells. University of Birmingham. M.Sc.
|
Done2025MScbyRes.pdf
Text - Accepted Version Available under License All rights reserved. Download (5MB) |
Abstract
Chronic T-cell receptor (TCR) stimulation is a central driver of CD4+ T-cell hyporesponsiveness. During prolonged stimulation, CD4+ T-cells either enter a state of tolerance, mimicking anergy, or differentiate into type-1 regulatory T-cells (Tr1), a distinct FoxP3- regulatory T-cell (Treg) subset crucial for maintaining immune tolerance via IL10 production. The specific regulators of adaptive tolerance, and how they differ from CD8+ T-cell exhaustion, remain unclear. Moreover, the signalling dynamics within Tr1-like cells and their environmental modulation are not well understood yet are of significant therapeutic interest. To study chronic-stimulation induced tolerance, Nur77-Tempo mice received escalation dose immunotherapy, allowing us to analyse NFAT-independent TCR signalling. Our study reveals that chronic stimulation-induced tolerance in CD4+ T-cells is associated with increased immune checkpoint (IC) expression and increased Tr1-like selection. These tolerised T-cells display intrinsic signalling defects in multiple T-cell signalling pathways which can be reversed by combined IC blockade (anti-PD-L1 and anti-Lag3) in-vivo. Importantly, Tr1-like cells remain responsive to chronic antigen exposure and exhibit heightened sensitivity to IC blockade. While the total and responsive Tr1-like cell populations increase following combination therapy, IL10 expression levels remain stable, indicating that ICs may regulate IL10 production within Tr1-like cells. We conclude that shared biological mechanisms underpin different forms of T-cell dysfunction, including tolerance and exhaustion. ICs are pivotal in enforcing tolerance, yet their function evolves following Tr1 differentiation, supporting the maintenance of a tolerogenic state. These findings suggest a need for further research to understand the impact of IC blockade on Tr1-like cells in various disease contexts, including cancer.
| Type of Work: | Thesis (Masters by Research > M.Sc.) |
|---|---|
| Award Type: | Masters by Research > M.Sc. |
| Supervisor(s): | Supervisor(s) Email ORCID Bending, David UNSPECIFIED UNSPECIFIED Dimeloe, Sarah UNSPECIFIED UNSPECIFIED |
| Licence: | All rights reserved |
| College/Faculty: | Colleges > College of Medicine and Health |
| School or Department: | School of Infection, Inflammation and Immunology, Department of Immunology and Immunotherapy |
| Funders: | None/not applicable |
| Subjects: | R Medicine > RC Internal medicine |
| URI: | https://bham-theses.eprints-hosting.org/id/eprint/16304 |
Actions
![]() |
Request a Correction |
![]() |
View Item |
Downloads
Downloads per month over past year
Tools
Tools
